Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2021 first-quarter earnings
Lede-What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings.jpg

What you need to know about Johnson & Johnson’s 2021 first-quarter earnings

Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Share Article
share to
90.png

This morning, Johnson & Johnson shared its first-quarter performance.

For more than 130 years, the company has aimed to make people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, with approximately 135,000 employees across the globe, the organization is striving to put a healthy mind, body and environment within reach of everyone, everywhere.

“Our strong first-quarter performance was primarily driven by above market growth in our pharmaceutical segment and continued recovery in our medical device unit,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are more confident than ever in the resilience of our diversified portfolio and the unwavering commitment of our Johnson & Johnson colleagues to deliver life-enhancing medicines and products to patients and customers around the globe. We remain focused on creating long-term value for all our stakeholders and investing in innovation that helps to further our goal of changing the trajectory of health for humanity.”

For more details about the company’s 2021 first-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


2021 Johnson & Johnson First Quarter Earnings Infographic

Johnson & Johnson’s 2021 1st-Quarter Earnings

Read the earnings press release, which includes full financial details for the first quarter of 2021.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.